TLIS — Talis Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Talis Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	21.6	138	233	130	76.7
Net Total Accounts Receivable
Net Total Receivables	1.81	0.471	0.183	0.308	0.05
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24.1	189	236	133	77.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.53	9.68	23.4	34.2	15.4
Other Long Term Assets
Total Assets	25.7	198	266	169	94.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.04	16	19.1	12.7	8.77
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.12	16	31.9	42.6	25.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	21.6	182	234	127	69.1
Total Liabilities & Shareholders' Equity	25.7	198	266	169	94.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding